// App-Quantinova.ai

11015 : Evaluation of quality of life at progression in patients with soft tissue sarcoma.

Researchers

Presenter

  • Stacie Hudgens

Principal Investigators

  • Anna Forsythe

  • Ilias Kontoudis

  • David R. D'Adamo

  • Ashley Bird

  • Hans Gelderblom

Medical Centers

  • Clinical Outcomes Solutions, Tucson, AZ

  • Eisai Inc, Woodcliff Lake, NJ

  • Eisai, Hatfield, Hertfordshire, United Kingdom

  • Eisai Inc, Woodcliff Lake, NJ

  • Leiden University Medical Center, Department of Clinical Pharmacy and Toxicology, Leiden, Netherlands

Locations

  • United States

  • United Kingdom

  • Netherlands

Companies

  • Clinical Outcomes So

  • Eisai Inc.

Study Components

Therapeutic Area

  • Genetic Disorder

  • Musculoskeletal

Disease

  • Soft tissue sarcoma

  • Solid malignancies

  • Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis

Biomarkers

  • N/A

Drug/Treatment

  • dacarbazine Intravenous

  • Eribulin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved